BioDelivery Sciences International (FRA:BD5) Total Assets : €287.3 Mil (As of Dec. 2021)

View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Total Assets?

BioDelivery Sciences International's Total Assets for the quarter that ended in Dec. 2021 was €287.3 Mil.

Warning Sign:

If a company builds asset at 50.9% a year, faster than its revenue growth rate of 32.7% over the past 5 years, it means that the company may be getting less efficent.

During the past 12 months, BioDelivery Sciences International's average Total Assets Growth Rate was 63.90% per year. During the past 3 years, the average Total Assets Growth Rate was 48.10% per year. During the past 5 years, the average Total Assets Growth Rate was 50.90% per year. During the past 10 years, the average Total Assets Growth Rate was 35.30% per year.

During the past 13 years, BioDelivery Sciences International's highest 3-Year average Total Assets Growth Rate was 82.10%. The lowest was -7.40%. And the median was 24.20%.

Total Assets is connected with ROA %. BioDelivery Sciences International's annualized ROA % for the quarter that ended in Dec. 2021 was 89.59%. Total Assets is also linked to Revenue through Asset Turnover. BioDelivery Sciences International's Asset Turnover for the quarter that ended in Dec. 2021 was 0.15.

BioDelivery Sciences International Total Assets Historical Data

The historical data trend for BioDelivery Sciences International's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Total Assets Chart

BioDelivery Sciences International Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Assets

Get a 7-Day Free Trial

74.45

95.40

164.62

197.19

287.27

BioDelivery Sciences International Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Total Assets	Get a 7-Day Free Trial															197.19	203.39	207.77	217.66	287.27

BioDelivery Sciences International Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

BioDelivery Sciences International's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (A: Dec. 2021 )	+	Total Liabilities (A: Dec. 2021 )
	=	166.222	+	121.045
	=	287.3

BioDelivery Sciences International's Total Assets for the quarter that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2021 )	+	Total Liabilities (Q: Dec. 2021 )
	=	166.222	+	121.045
	=	287.3

BioDelivery Sciences International (FRA:BD5) Total Assets Explanation

Total Assets is connected with ROA %.

BioDelivery Sciences International's annualized ROA % for the quarter that ended in Dec. 2021 is

ROA %	=	Net Income (Q: Dec. 2021 )	/	( (Total Assets (Q: Sep. 2021 )	+	Total Assets (Q: Dec. 2021 ))	/ count )
	=	226.172	/	( (217.66	+	287.267)	/ 2 )
	=	226.172	/	252.4635
	=	89.59 %

Note: The Net Income data used here is four times the quarterly (Dec. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

BioDelivery Sciences International's Asset Turnover for the quarter that ended in Dec. 2021 is

	Asset Turnover
=	Revenue (Q: Dec. 2021 )	/	( (Total Assets (Q: Sep. 2021 )	+	Total Assets (Q: Dec. 2021 ))	/ count )
=	38.191	/	( (217.66	+	287.267)	/ 2 )
=	38.191	/	252.4635
=	0.15

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

BioDelivery Sciences International Total Assets Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (FRA:BD5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612

Website

http://www.bdsi.com

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines